Sotera Health Co (SHC)
11.41
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
11.42
0.00 (0.00%)
After-Hours: 20:00
Sotera Health Price to Book Value: 7.525 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 15, 2024 | 7.522 |
| May 14, 2024 | 7.515 |
| May 13, 2024 | 7.502 |
| May 10, 2024 | 7.278 |
| May 09, 2024 | 7.469 |
| May 08, 2024 | 7.393 |
| May 07, 2024 | 7.561 |
| May 06, 2024 | 7.443 |
| May 03, 2024 | 7.265 |
| May 02, 2024 | 7.192 |
| May 01, 2024 | 7.430 |
| April 30, 2024 | 7.383 |
| April 29, 2024 | 7.502 |
| April 26, 2024 | 7.515 |
| April 25, 2024 | 7.463 |
| April 24, 2024 | 7.430 |
| April 23, 2024 | 7.502 |
| April 22, 2024 | 7.311 |
| April 19, 2024 | 7.219 |
| April 18, 2024 | 7.186 |
| April 17, 2024 | 7.087 |
| April 16, 2024 | 7.179 |
| April 15, 2024 | 7.258 |
| April 12, 2024 | 7.436 |
| April 11, 2024 | 7.528 |
| Date | Value |
|---|---|
| April 10, 2024 | 7.528 |
| April 09, 2024 | 7.660 |
| April 08, 2024 | 7.515 |
| April 05, 2024 | 7.476 |
| April 04, 2024 | 7.515 |
| April 03, 2024 | 7.608 |
| April 02, 2024 | 7.502 |
| April 01, 2024 | 7.713 |
| March 31, 2024 | |
| March 28, 2024 | 7.662 |
| March 27, 2024 | 7.566 |
| March 26, 2024 | 7.349 |
| March 25, 2024 | 7.489 |
| March 22, 2024 | 7.202 |
| March 21, 2024 | 7.356 |
| March 20, 2024 | 7.508 |
| March 19, 2024 | 8.356 |
| March 18, 2024 | 9.134 |
| March 15, 2024 | 9.255 |
| March 14, 2024 | 9.038 |
| March 13, 2024 | 8.885 |
| March 12, 2024 | 8.777 |
| March 11, 2024 | 8.924 |
| March 08, 2024 | 8.815 |
| March 07, 2024 | 8.911 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.767
Minimum
Nov 17 2022
18.13
Maximum
Mar 12 2021
11.01
Average
10.98
Median
May 30 2023
Price to Book Value Benchmarks
| Fonar Corp | 0.6232 |
| XWELL Inc | 0.5856 |
| ProPhase Labs Inc | 2.173 |
| Applied DNA Sciences Inc | -- |
| Veracyte Inc | 1.598 |
Price to Book Value Related Metrics
| PE Ratio | 60.08 |
| PS Ratio | 2.999 |
| Price | 11.41 |
| Earnings Yield | 1.66% |
| Market Cap | 3.231B |
| Operating PE Ratio | 10.89 |
| Normalized PE Ratio | 39.85 |